Cargando…
Is cytomegalovirus reactivation increasing the mortality of patients with severe sepsis?
Cytomegalovirus (CMV) is a ubiquitous virus present in approximately two-thirds of the healthy population. This virus rarely causes an active disease in healthy individuals, but it is among the most common opportunistic infections in immunocompromised patients such as solid organ transplant recipien...
Autores principales: | Kalil, Andre C, Florescu, Diana F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3219353/ https://www.ncbi.nlm.nih.gov/pubmed/21457496 http://dx.doi.org/10.1186/cc10093 |
Ejemplares similares
-
Severe sepsis: are PROWESS and PROWESS-SHOCK trials comparable? A clinical and statistical heterogeneity analysis
por: Kalil, Andre C, et al.
Publicado: (2013) -
The complex link between influenza and severe sepsis
por: Florescu, Diana F, et al.
Publicado: (2014) -
Consequences of cytomegalovirus reactivation in patients with severe sepsis
por: Heininger, A, et al.
Publicado: (2007) -
Does reactivation of cytomegalovirus contribute to severe COVID-19 disease?
por: Söderberg-Nauclér, Cecilia
Publicado: (2021) -
Cytomegalovirus reactivation and associated outcome of critically ill patients with severe sepsis
por: Heininger, Alexandra, et al.
Publicado: (2011)